Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Price:
0.06 USD
6.19%
Market Closed
Updated:
May 9, 2024
Cash Flow Statement
Cash Flow Statement
Aridis Pharmaceuticals Inc
Aridis Pharmaceuticals Inc
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(42)
|
(43)
|
(46)
|
(33)
|
(30)
|
(29)
|
(9)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
8
|
9
|
9
|
3
|
2
|
1
|
0
|
(1)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
11
|
5
|
7
|
4
|
(1)
|
5
|
(12)
|
(16)
|
|
| Cash from Operating Activities |
(23)
N/A
|
(29)
-27%
|
(29)
+2%
|
(24)
+15%
|
(29)
-20%
|
(23)
+21%
|
(21)
+8%
|
(18)
+16%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+59%
|
(0)
+52%
|
0
N/A
|
(0)
N/A
|
(0)
+26%
|
(0)
+43%
|
(0)
N/A
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
30
|
23
|
23
|
(0)
|
13
|
15
|
15
|
16
|
|
| Net Issuance of Debt |
5
|
10
|
10
|
10
|
5
|
0
|
2
|
3
|
|
| Other |
0
|
(1)
|
(1)
|
(1)
|
(3)
|
(4)
|
(3)
|
(4)
|
|
| Cash from Financing Activities |
35
N/A
|
33
-6%
|
33
+0%
|
9
-73%
|
15
+70%
|
11
-28%
|
14
+30%
|
15
+11%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
11
N/A
|
3
-71%
|
4
+18%
|
(16)
N/A
|
(14)
+7%
|
(12)
+14%
|
(7)
+40%
|
(3)
+65%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(23)
N/A
|
(29)
-25%
|
(29)
+2%
|
(24)
+15%
|
(29)
-20%
|
(23)
+21%
|
(21)
+8%
|
(18)
+15%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
